Rendu-Osler and Bevacizumab
收藏B2FIND2026-03-21 收录
官方服务：
资源简介：
Bevacizumab, an anti-VEGF monoclonal antibody, has recently emerged as a new option for severe forms of hereditary hemorrhagic telangiectasia (HHT). Its utilization in this...
贝伐珠单抗（Bevacizumab）作为一种抗血管内皮生长因子单克隆抗体，近期已成为治疗重型遗传性出血性毛细血管扩张症（HHT）的全新治疗选择。其在该疾病中的应用……
